☆ 4.5 Letter

Clinical outcomes of coronavirus disease 2019 (COVID-19) in cancer patients with prior exposure to immune checkpoint inhibitors

CANCER COMMUNICATIONS (2020)

Get Full Text
Add to Collection

Journal

CANCER COMMUNICATIONS
Volume 40, Issue 8, Pages 374-379

Publisher

WILEY
DOI: 10.1002/cac2.12077

Keywords

-

Categories

Oncology

Funding

  1. National Medical Research Council Clinician-scientist award [NMRC/CSA/0027/2018]
  2. Health Commission of Hubei Province Scientific Research Project [WJ2019H002]
  3. Health Commission of Hubei Province Medical Leading Talent Project
  4. Fundamental Research Funds for the Central Universities [2042018kf1037, 2042019kf0329]
  5. Medical Science Advancement Program (Basic Medical Sciences) of Wuhan University [TFJC2018005]
  6. Zhongnan Hospital of Wuhan University Science, Technology and Innovation Seed Fund [znpy2017049, znpy2018070]

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.